Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment.
- DOI
- 10.1007/s12325-026-03697-y
- Published
- 2026-09-15
- Container
- Adv Ther
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03697-y,
title = {Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment.},
author = {Cutler AJ and Gonzalez A and Suett M and Shulman K and Franzenburg KR and Tucker JL and Costa E and Lim S.},
year = {2026},
journal = {Adv Ther},
doi = {10.1007/s12325-026-03697-y},
url = {https://doi.org/10.1007/s12325-026-03697-y}
}RIS
TY - JOUR TI - Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment. AU - Cutler AJ AU - Gonzalez A AU - Suett M AU - Shulman K AU - Franzenburg KR AU - Tucker JL AU - Costa E AU - Lim S. PY - 2026 JO - Adv Ther DO - 10.1007/s12325-026-03697-y UR - https://doi.org/10.1007/s12325-026-03697-y ER -
APA
AJ, C., A, G., M, S., K, S., KR, F., JL, T., E, C., & S., L. (2026). Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment.. Adv Ther. https://doi.org/10.1007/s12325-026-03697-y
Source records
- europe-pmc · retrieved 2026-09-26T01:22:15.104Z